Your browser doesn't support javascript.
loading
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy.
Allen, W L; Dunne, P D; McDade, S; Scanlon, E; Loughrey, M; Coleman, H; McCann, C; McLaughlin, K; Nemeth, Z; Syed, N; Jithesh, P; Arthur, K; Wilson, R; Coyle, V; McArt, D; Murray, G I; Samuel, L; Nuciforo, P; Jimenez, J; Argiles, G; Dienstmann, R; Tabernero, J; Messerini, L; Nobili, S; Mini, E; Sheahan, K; Ryan, E; Johnston, P G; Van Schaeybroeck, S; Lawler, M; Longley, D B.
Afiliación
  • Allen WL; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Dunne PD; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • McDade S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Scanlon E; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Loughrey M; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Coleman H; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • McCann C; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • McLaughlin K; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Nemeth Z; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Syed N; Sidra Medical and Research Center, Qatar.
  • Jithesh P; Sidra Medical and Research Center, Qatar.
  • Arthur K; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Wilson R; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Coyle V; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • McArt D; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Murray GI; NHS Grampian, Aberdeen.
  • Samuel L; NHS Grampian, Aberdeen.
  • Nuciforo P; University Hospital Vall d'Hebron, Barcelona, Spain.
  • Jimenez J; University Hospital Vall d'Hebron, Barcelona, Spain.
  • Argiles G; University Hospital Vall d'Hebron, Barcelona, Spain.
  • Dienstmann R; University Hospital Vall d'Hebron, Barcelona, Spain.
  • Tabernero J; University Hospital Vall d'Hebron, Barcelona, Spain.
  • Messerini L; University of Florence, Italy.
  • Nobili S; University of Florence, Italy.
  • Mini E; University of Florence, Italy.
  • Sheahan K; School of Medicine and Medical Science, University College Dublin.
  • Ryan E; School of Medicine and Medical Science, University College Dublin.
  • Johnston PG; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Van Schaeybroeck S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Lawler M; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Longley DB; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
JCO Precis Oncol ; 20182018 Jun 13.
Article en En | MEDLINE | ID: mdl-30088816
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido